Global Osteopathic Treatment for Patients With NAFLD
NCT03156881 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48
Last updated 2017-05-17
Summary
Non-alcoholic fatty liver disease is a complex disease that is growing more prominent around the world especially in North America because of high prevalence of overweightness and obesity. There are many factors that are associated with this illness and it does not seem to be the same in every patient. The progression of this disease can with time lead to liver cirrhosis and even primary liver cancer (hepatocellular carcinoma). Currently, the only treatment plan involves diet change and exercise.
The goal of this research is to validate that Osteopathy can optimise patient health and to potentially be another option in preventing/reducing progression of this disease. This research is important for the future of Osteopathy to educate the public and other therapists/physicians the benefits this manual therapy has to offer. Previous research has been done and shown that Osteopathy can help patients with low back pain and type two diabetes, by affecting glucose and insulin levels with manipulation of the spine and pancreas.
Another study compared one group of obese patients with chronic low back pain that just did specific exercises to another group that were given exercises as well as Osteopathic manual therapy (OMT). Results showed both groups had reduced pain, however only the group with additional OMT showed improved range of motion in the thoracic spine, and showed greater degree of improvement overall for these patients. This study shows how OMT can be effective for individuals with NAFLD for in general these patients are obese and part of their treatment regime is to exercise to lose weight. The researcher could not find any previous research on OMT contributing to weight loss, however according to the Reve Pavilion natural health clinic website (2015), OMT can improve underlying issues such as low back pain, preventing the person to exercise effectively. The researcher also hopes to gain further knowledge of this subject, and to show the benefits of collaborating Osteopathy and Allopathic medicine together to obtain optimal patient care.
Conditions
- Non-Alcoholic Fatty Liver Disease
Interventions
- OTHER
-
Global Osteopathic Treatment
The study objectives is to observe a difference and improvement of liver function based on liver enzyme count from blood work after osteopathic treatments. Also to observe an improvement in the patients quality of life after receiving treatment and in their readiness to change. Osteopathy is a type of manual therapy that uses gentle manipulations taking into consideration of the whole person when treating. For example if the liver is being treated, osteopaths look for mobility, to carry out its proper function. However one will also assess its interrelationships that can influence the liver such as its neighbours, articulating structures, example the diaphragm as well as its neurological input from T5-T9 for instance.
Sponsors & Collaborators
-
Jenna Wilcox
lead OTHER
Principal Investigators
-
Kevork Peltekian, MD, FRCPC · Division of Digestive Care & Endoscopy , Department of Medicine , Department of Surgery
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-31
- Primary Completion
- 2017-11-30
- Completion
- 2018-05-31
More Related Trials
-
Intermittent Fasting for NAFLD in Adults
NCT04899102 ·Status: RECRUITING ·Phase: NA
-
Fatty Liver in Obesity: Long-lifestyle Follow-up (FLiO)
NCT03183193 ·Status: UNKNOWN ·Phase: NA
-
Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients
NCT04059029 ·Status: UNKNOWN
-
Impact of Weight Loss in Cirrhosis With Obesity and MAFLD
NCT05104541 ·Status: UNKNOWN ·Phase: NA
-
Effect of Fatty Liver Disease on Bone Density
NCT04850547 ·Status: UNKNOWN
-
Palmitate Breath Test to Assess Fatty Acid Oxidation in Non Alcoholic Fatty Liver Disease (NAFLD)
NCT02363309 ·Status: COMPLETED
-
Impact of Weight Loss Surgery in Adolescents With NAFLD
NCT02952170 ·Status: COMPLETED ·Phase: NA
-
Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies
NCT06135584 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)
NCT00983463 ·Status: ENROLLING_BY_INVITATION
-
Impact of Live Streaming Exercise on Liver Health in MASLD Pregnant Women
NCT06682663 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prevalence of MAFLD Among Nurses and the Role of Intermittent Fasting
NCT05880316 ·Status: UNKNOWN ·Phase: NA
-
Validity of Laboratory Biomarkers in Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) and It's Consequences
NCT06908122 ·Status: NOT_YET_RECRUITING
-
Alternate Day Fasting, Exercise, and NAFLD
NCT04004403 ·Status: COMPLETED ·Phase: NA
-
Inflammation and Obesity-associated Disease
NCT02322073 ·Status: RECRUITING
-
Lifestyle Intervention in Fatty Liver (NAFLD)
NCT03354247 ·Status: UNKNOWN ·Phase: NA
-
The Impact of Non-Alcoholic Fatty Pancreas Disease on Outcome of Acute Pancreatitis
NCT03394378 ·Status: COMPLETED
-
Metabolic Subtypes of Non-Alcoholic Fatty Liver Disease
NCT05560997 ·Status: UNKNOWN
-
A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes
NCT07241195 ·Status: NOT_YET_RECRUITING
-
Low Glycemic Index Dietary Intervention Program in Nonalcoholic Fatty Liver Disease
NCT00868933 ·Status: COMPLETED ·Phase: NA
-
Effect of Weight Loss on Body Composition and Metabolic Function in Women With Lipedema
NCT03271034 ·Status: COMPLETED ·Phase: NA
-
Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
NCT05890365 ·Status: RECRUITING
-
Liver Enzymes and Metabolic Risk Factors Response to Laser Acupuncture Versus Cupping Therapy in Fatty Liver
NCT05623930 ·Status: UNKNOWN ·Phase: NA
-
Genetic Pathways Leading to Fatty Liver and Atherogenic Dyslipidemia
NCT04209816 ·Status: ENROLLING_BY_INVITATION
-
Evaluation of Gut Permeability in Patients Affected by Obesity and NAFLD: Influence of Ketogenic Diet.
NCT05477212 ·Status: RECRUITING ·Phase: NA
-
Role Of Serum Adiponectin In The Ealy Detection Of Renal Impairment In Patients With Non Alcoholic Fatty Liver Disease
NCT05556135 ·Status: UNKNOWN